In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota

Diagnostic Microbiology and Infectious Disease

Volumn 45, Issue 3, 2003, Pages 199-202

  Gómez López, Alicia ^a   Cuenca Estrella, Manuel ^a   Mellado, Emilia ^a   Rodríguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; TERBINAFINE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INTERACTION; DRUG POTENTIATION; FUNGAL STRAIN; FUNGUS ISOLATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS ORYZAE; ZYGOMYCETES;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; COLONY COUNT, MICROBIAL; DRUG INTERACTIONS; FEMALE; HUMANS; ITRACONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MYCOSES; NAPHTHALENES; SENSITIVITY AND SPECIFICITY; ZYGOMYCOTA;

EID: 0037345602     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00509-6     Document Type: Article

References (13)

1. Barchiesi F., Di Francesco L.F., Scalise G. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrob Agents Chemother. 41:1997;1812-1814.
2. Dannaoui E., Afeltra J., Meis J.F.G.M., Verweij P.E. In vitro susceptibilities of Zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother. 46:2002;2708-2711.
3. Te Dorsthorsth D.T.A., Verweij P.E., Meis J.F.G.M., Punt N.C., Mounton J.W. Comparation of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates. Antimicrob Agents Chemother. 46:2002;702-707.
4. Eliopoulos G.M., Moellering R.C. Jr. Antimicrobial combinations. Lorian V. Antibiotics in Laboratory Medicine. 3rd ed. 1991;432-492 Williams & Wilkins, Baltimore, MD.
5. Gómez-López A., Cuenca-Estrella M., Monzón A., Rodriguez-Tudela J.L. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole, and voriconazole. J Antimicrob Chemother. 48:2001;919-921.
6. Klepser M.E., Lewis R.E., Ernst E.J., et al. Multi-center evaluation of antifungal time-kill methods. J Infect Dis Pharmacother. 5:2001;29-41.
7. Meletiadis J., Mouton J.W., Rodriguez-Tudela J.L., Meis J.F., Verweij P.E. In vitro interaction of Terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother. 44:2002;470-472.
8. National Committee for Clinical Laboratory Standards. (1998). Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard. NCCLS document M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Norden G., Bjorck S., Persson H., Svalander C., Li X., Edebo L. Cure of zygomycosis caused by a lipase-producing Rhizopus rhizopodiformis strain in a renal transplant patient. Scand J Infect Dis. 23:1991;377-382.
10. Petrikkou E., Rodríguez-Tudela J.L., Cuenca-Estrella M., Gómez A., Molleja A., Mellado E. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J Clin Microbiol. 39:2001;1345-1347.
11. Ribes J.A., Vanover-Sams C.L., Baker D.J. Zygomycetes in human disease. Clin Microbiol Rev. 13:(2):2000;236-301.
12. Ryder N.S., Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol. 39:2001;91-95.
13. Sugar A.M., Liu X.P. Combination antifungal therapy in treatment of murine pulmonary mucormycosis roles of quinolone and azoles . Antimicrob Agents Chemother. 44:2000;2004-2006.